N-Allyl-3-chlorobenzamide

Catalog No.: 
ACFRVT579
CAS No.: 
35306-52-6
Molecular Formula: 
C10H10ClNO
Molecular Weight: 
195.65
N-Allyl-3-chlorobenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$350.00InquiryInquiry
1g97%$426.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Allyl-3-chlorobenzamide
IUPAC NameN-allyl-3-chlorobenzamide
MDL No.MFCD01181345
Molecular FormulaC10H10ClNO
Molecular Weight195.65
SMILESO=C(C1=CC=CC(Cl)=C1)NCC=C
InChI KeyAYYLDFQIHWYQJO-UHFFFAOYSA-N
SynonymN-ALLYL-3-CHLOROBENZENECARBOXAMIDE;Benzamide, 3-chloro-N-2-propen-1-yl-;N-allyl-3-chlorobenzamide;3-Chloro-N-(prop-2-en-1-yl)benzamide
CAS No.35306-52-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFRVT579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLTP679 route compound structure diagram
    ACXLTP67910017-11-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRVT579 route product structure diagram
    ACFRVT57935306-52-6
Inquiry

2. ACFRVT579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLTP679 route compound structure diagram
    ACXLTP67910017-11-5In Stock
  2. Plus
  3. ACZDCA319 route compound structure diagram
    ACZDCA319535-80-8In Stock
  4. Then
  5. ACFRVT579 route product structure diagram
    ACFRVT57935306-52-6
Inquiry

3. ACFRVT579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLTP679 route compound structure diagram
    ACXLTP67910017-11-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRVT579 route product structure diagram
    ACFRVT57935306-52-6
Inquiry

Comments (0)